Significant mortality benefits have been documented in recipients of implantable
cardioverter defibrillators (ICDs); however, the psychosocial distress created by the …

Background Patients with an implantable cardioverter defibrillator (ICD) retain a scar and a
bump at the site of implant. This may lead to body image concerns (BICs) that influence …

A subset of patients with an implantable cardioverter defibrillator (ICD) reports psychological
distress and poor quality of life (QoL). Gender is one of the factors that has been proposed to …

BACKGROUND: Sudden cardiac death is an international health issue. Implantable
defibrillators have been effective in the secondary prevention of sudden cardiac death and …

Objective To review current literature regarding depression and anxiety in women with
cardiovascular disease. Data Sources Publications retrieved from database searches using …

Background While randomised, controlled trials have established the efficacy of the
implantable cardioverter defibrillator (ICD) for primary and secondary prevention of life …

Aims and objectives. This literature review aims to critically appraise any published studies
that compare the experiences of patients with permanent pacemakers and those with …

Background: Sudden cardiac death is a leading cause of death in the Americas and Europe.
Although the implantable cardioverter defibrillator (ICD) has decreased mortality from …

Population aging and broader indications for the implant of cardiac implantable electronic
devices (CIEDs) are the main reasons for the continuous increase in the use of pacemakers …

It has been estimated that 180,000–450,000 people die suddenly in the US every year.
Currently, the most effective method for reducing the risk of sudden death in those patients at …